loading
Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt REGN? Forum Prognose

Warum fällt Regeneron Pharmaceuticals, Inc.-Aktie (REGN)?

2023-06-27:

REGN's stock fell 8.71% following The Food and Drug Administration (FDA)'s rejection of an 8-milligram-dose version of Regeneron Pharmaceuticals' eye drug Eylea.

https://www.investors.com/news/technology/regn-stock-crumbles-after-the-fda-rejects-its-next-possible-blockbuster/?src=A00220

Ähnlich wie REGN

biotechnology VRTX
$433.97
price up icon 1.24%
biotechnology MRNA
$125.71
price down icon 2.10%
biotechnology BNTX
$92.23
price down icon 0.05%
biotechnology ARGX
$372.30
price up icon 4.57%
biotechnology GMAB
$30.30
price up icon 2.58%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen
Kapitalisierung:     |  Volumen (24h):